Fiduciary Family Office LLC Has $510,000 Stake in CME Group Inc. (NASDAQ:CME)

Fiduciary Family Office LLC lessened its position in shares of CME Group Inc. (NASDAQ:CME) by 16.2% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,593 shares of the financial services provider’s stock after selling 503 shares during the period. Fiduciary Family Office LLC’s holdings in CME Group were worth $510,000 at the end of the most recent reporting period.

A number of other institutional investors have also bought and sold shares of the company. Gold Investment Management Ltd. acquired a new stake in shares of CME Group in the 4th quarter valued at about $26,000. Salomon & Ludwin LLC acquired a new position in shares of CME Group during the first quarter worth approximately $28,000. Northwest Financial Advisors bought a new position in shares of CME Group in the 4th quarter worth $28,000. Rise Advisors LLC acquired a new stake in CME Group in the 1st quarter valued at $41,000. Finally, McClarren Financial Advisors Inc. grew its position in CME Group by 66.1% in the 2nd quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 78 shares during the period. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of CME traded down $6.67 during mid-day trading on Tuesday, hitting $209.07. The stock had a trading volume of 475,450 shares, compared to its average volume of 1,910,043. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $223.80. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The business has a fifty day moving average price of $201.77 and a 200-day moving average price of $207.41. The firm has a market cap of $75.28 billion, a P/E ratio of 24.54, a PEG ratio of 6.51 and a beta of 0.52.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share for the quarter, topping the consensus estimate of $2.53 by $0.03. The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm’s revenue for the quarter was up 12.7% on a year-over-year basis. During the same quarter last year, the firm posted $2.30 EPS. On average, equities research analysts expect that CME Group Inc. will post 9.89 EPS for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be issued a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.20%. CME Group’s payout ratio is 52.33%.

Analysts Set New Price Targets

CME has been the subject of a number of analyst reports. Bank of America cut shares of CME Group from a “neutral” rating to an “underperform” rating and reduced their price objective for the company from $212.00 to $177.00 in a report on Tuesday. Piper Sandler reissued an “overweight” rating and issued a $225.00 price objective on shares of CME Group in a research note on Tuesday, August 20th. Barclays lifted their target price on CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a research report on Thursday, July 25th. Deutsche Bank Aktiengesellschaft increased their price target on CME Group from $193.00 to $200.00 and gave the company a “hold” rating in a research report on Thursday, August 15th. Finally, Keefe, Bruyette & Woods upped their target price on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research note on Thursday, July 25th. Four analysts have rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $209.73.

Insiders Place Their Bets

In other CME Group news, Director Charles P. Carey sold 3,000 shares of the firm’s stock in a transaction dated Thursday, June 13th. The stock was sold at an average price of $195.44, for a total value of $586,320.00. Following the completion of the transaction, the director now owns 7,163 shares in the company, valued at approximately $1,399,936.72. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other CME Group news, Director Daniel R. Glickman sold 650 shares of CME Group stock in a transaction that occurred on Thursday, June 6th. The shares were sold at an average price of $201.44, for a total transaction of $130,936.00. Following the completion of the sale, the director now directly owns 14,008 shares in the company, valued at $2,821,771.52. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Charles P. Carey sold 3,000 shares of CME Group stock in a transaction on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total transaction of $586,320.00. Following the sale, the director now directly owns 7,163 shares of the company’s stock, valued at $1,399,936.72. The disclosure for this sale can be found here. Company insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.